A61K 38/415
Cytochromes
Official title: {Cytochromes}
A61K38/415 (Cytochromes) appears on 14 US grants and 24 published applications in this corpus.
Search patents in A61K- Granted patents
- 14
- Published applications
- 24
- Assignees
- 18
- Inventors
- 79
- Latest grant
- 26 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 1 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 3 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 1 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 2 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 0 | 2 |
| 2019 | 1 | 2 |
| 2020 | 2 | 1 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 2 |
| 2024 | 0 | 2 |
| 2025 | 2 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Ubiquitous antigens for treatment of autoimmune or inflammatory diseases26 Aug 2025US 12,397,038 B2UTI Limited Partnership
- Recombinant adeno-associated viral vectors for treating Bietti Crystalline Dystrophy29 Jul 2025US 12,371,474 B2Shanghai Vitalgen Biopharma Co., Ltd.
- Use of microperoxidases for the treatment of carboxyhemoglobinemia20 Apr 2021US 10,980,864 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Disintegratable core/shell silica particles for encapsulating and releasing bioactive macromolecules3 Nov 2020US 10,821,082 B2Universite De Strasbourg
- Method of obtaining a pharmacologically active liposomal cytochrome c and nitric oxide complex15 Sep 2020US 10,772,835 B2
- Recombinant adeno-associated viral vectors for treating bietti crystalline dystrophy19 Sep 2024US 2024/0309068 A1Shanghai Vitalgen Biopharma Co., Ltd.
- Catechol Nanoparticle, Catechol Protein Nanoparticle, and Preparation Method and Use Thereof21 Mar 2024US 2024/0091170 A1Shihezi University
- Methods and compositions for treating amyotrophic lateral sclerosis7 Sep 2023US 2023/0277630 A1
- Products and methods for the treatment of nicotine dependence6 Jul 2023US 2023/0212533 A1The Board of Trustees of Western Michigan University
- Encapsulated cells producing cytochrome p450 and methods of use thereof11 Nov 2021US 2021/0346304 A1PharmaCyte Biotech, Inc.
Most cited
By later US patents
- Cytotoxic factors for modulating cell death8US 7,491,394 B2The Board of Trustees of the University of Illinois · 2009
- Antihypoxic formulation4US 5,439,883 A1995
- Cytotoxic factors for modulating cell death4US 7,888,468 B2The Board of Trustees of the University of Illinois · 2011
- Factors which interact with oncoproteins3US 6,204,253 B1Ludwig Institute for Cancer Research · 2001
- Cardiotropic formulation2US 5,602,105 A1997